6 Tweets 13 reads Sep 04, 2021
#StelisBioPharma is producing 200mn doses for Sputnik for RDIF
Even if they sell each doze for Rs 200, that's almost 4K cr in sales
Strides owns 33% of Stelis, so 1.6Kcr in sales
Sales of Strides = 3316cr + 1.6Kcr + 0.8cr (Stelis value)
Market Cap = 7kcr
Selling for ~1x sales
Still selling for ~1x sales after taking account for below mentioned correction.
Sputnik V, explained
youtube.com
For all questions, relating to what happens after vaccine 👇🏼
stelisbiosource.com

Loading suggestions...